MétaCan
Menu
Back to cohort
Record W3213355394 · doi:10.5742/mewfm.2021.94158

Impact of COVID-19 on patients receiving chemotherapy for gynecological cancer

2021· article· en· W3213355394 on OpenAlexfundno aff
Mahmoud N. Andijani, Ahmad O Alibrahim, Sheren F. Tmraz, Lamees F. ALshenqity, Abdulaziz S. Alaama, Bayan A. Zaatari, Nisreen Anfinan, Khalid Sait

Bibliographic record

VenueWorld Family Medicine Journal /Middle East Journal of Family Medicine · 2021
Typearticle
Languageen
FieldMedicine
TopicCOVID-19 and healthcare impacts
Canadian institutionsnot available
FundersGrand Challenges CanadaKing Saud University
KeywordsMedicineChemotherapyCancerInternal medicineCoronavirus disease 2019 (COVID-19)DiseaseMedical recordPandemicCervical cancerOvarian cancerSurgeryGynecologyInfectious disease (medical specialty)

Abstract

fetched live from OpenAlex

Background: Cancer patients’ increased susceptibility to serious COVID-19 complications can be attributed to the immunosuppressed state caused by the disease and anticancer treatments such as chemotherapy or surgery. Objectives: To assess the effect of COVID-19 pandemic on gynecological cancer patients receiving chemotherapy. Methods: A cross-sectional study was conducted on patients receiving chemotherapy for gynecological cancer between (March 2020 to February 2021) at King Abdulaziz University Hospital (KAUH) in Jeddah, Saudi Arabia. Clinical data collected from medical records included patients’ ages, medical history data, cycles of chemotherapy, COVID-19 infection, complications and death. Results: Total of 84 patients were identified. The mean age of studied patients was 53.81 ± 13.76 years, and the most common chronic diseases were HTN (35.7%) and DM (23.8%). The majority of diagnoses were ovarian cancer (41.7%) followed by uterine cancer (33.3%). Of studied patients, 17.9%, 19.1%, 27.4 and 33.3% had I, II , III and IV cancer stages respectively. The mean number of cycles of chemotherapy was 7.14 ± 5.55. 52.4% had first line chemotherapy. 57 percent of patients had delays due to various causes, including COVID-19 infection, and 9 percent of patients had COVID-19 while on therapy. 15 percent of the delays were caused by patients who were affected by Covid-19 while receiving chemotherapy and 2% of the patients died as a result of COVID-19 . Patients with recurrent disease had a significantly higher percentage of patients detected with COVID-19, and all cases detected with COVID-19 died with respiratory failure. Patients who had their chemotherapy delayed had a significantly higher mean number of cycles. Conclusion: Improved communication and management programs are required to keep cancer patients and their healthcare providers connected, as well as to allow cancer patients to survive a pandemic. Key words: Impact, COVID-19, patients, chemotherapy, Jeddah, Saudi Arabia.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.229
GPT teacher head0.453
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueWorld Family Medicine Journal /Middle East Journal of Family MedicineSame topicCOVID-19 and healthcare impactsFrench-language works237,207